D Kearney, D Fitzgerald. Show Affiliations »
Abstract
Mesh: See more » Aspirin/therapeutic useBlood Coagulation Factors/drug effectsCholesterol, HDL/bloodCholesterol, HDL/drug effectsCholesterol, LDL/bloodCholesterol, LDL/drug effectsCoronary Thrombosis/bloodCoronary Thrombosis/etiologyCoronary Thrombosis/prevention & controlHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useHypercholesterolemia/bloodHypercholesterolemia/complicationsHypercholesterolemia/drug therapyPlatelet Aggregation Inhibitors/therapeutic useRandomized Controlled Trials as TopicThromboxane A2/bloodTreatment Outcome
Substances: See more » Blood Coagulation FactorsCholesterol, HDLCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsPlatelet Aggregation InhibitorsThromboxane A2Aspirin
Year: 1999 PMID: 10193731 DOI: 10.1016/s0735-1097(99)00019-4
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 24.094